Literature DB >> 22403793

Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.

Fadi Annaba1, Zaheer Sarwar, Ravinder K Gill, Amit Ghosh, Seema Saksena, Alip Borthakur, Gail A Hecht, Pradeep K Dudeja, Waddah A Alrefai.   

Abstract

Apical sodium-dependent bile acid transporter (ASBT) is responsible for the absorption of bile acids from the intestine. A decrease in ASBT function and expression has been implicated in diarrhea associated with intestinal inflammation. Whether infection with pathogenic microorganisms such as the enteropathogenic Escherichia coli (EPEC) affect ASBT activity is not known. EPEC is a food-borne enteric pathogen that translocates bacterial effector molecules via type three secretion system (TTSS) into host cells and is a major cause of infantile diarrhea. We investigated the effects of EPEC infection on ileal ASBT function utilizing human intestinal Caco2 cells and HEK-293 cells stably transfected with ASBT-V5 fusion protein (2BT cells). ASBT activity was significantly inhibited following 60 min infection with EPEC but not with nonpathogenic E. coli. Mutations in bacterial escN, espA, espB, and espD, the genes encoding for the elements of bacterial TTSS, ablated EPEC inhibitory effect on ASBT function. Furthermore, mutation in the bacterial BFP gene encoding for bundle-forming pili abrogated the inhibition of ASBT by EPEC, indicating the essential role for bacterial aggregation and the early attachment. The inhibition by EPEC was associated with a significant decrease in the V(max) of the transporter and a reduction in the level of ASBT on the plasma membrane. The inhibition of ASBT by EPEC was blocked in the presence of protein tyrosine phosphatase inhibitors. Our studies provide novel evidence for the alterations in the activity of ASBT by EPEC infection and suggest a possible effect for EPEC in influencing intestinal bile acid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403793      PMCID: PMC3362099          DOI: 10.1152/ajpgi.00017.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  29 in total

1.  An inducible bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; A S Ho; G K Schoolnik
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

2.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

3.  A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation.

Authors:  I Rosenshine; S Ruschkowski; M Stein; D J Reinscheid; S D Mills; B B Finlay
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

4.  Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli.

Authors:  C Wolff; I Nisan; E Hanski; G Frankel; I Rosenshine
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

5.  Mouse model of enteropathogenic Escherichia coli infection.

Authors:  Suzana D Savkovic; Jennilee Villanueva; Jerrold R Turner; Kristina A Matkowskyj; Gail Hecht
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts.

Authors:  Fadi Annaba; Zaheer Sarwar; Pradeep Kumar; Seema Saksena; Jerrold R Turner; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-12-06       Impact factor: 4.052

8.  Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients.

Authors:  Kacper A Wojtal; Jyrki J Eloranta; Petr Hruz; Heike Gutmann; Jürgen Drewe; Alex Staumann; Christoph Beglinger; Michael Fried; Gerd A Kullak-Ublick; Stephan R Vavricka
Journal:  Drug Metab Dispos       Date:  2009-06-01       Impact factor: 3.922

9.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

Authors:  Takeshi Inagaki; Antonio Moschetta; Youn-Kyoung Lee; Li Peng; Guixiang Zhao; Michael Downes; Ruth T Yu; John M Shelton; James A Richardson; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

10.  Enteropathogenic Escherichia coli inhibits phagocytosis.

Authors:  D L Goosney; J Celli; B Kenny; B B Finlay
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  14 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.

Authors:  Jessica Tsuei; Thinh Chau; David Mills; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

3.  N-glycosylation is essential for ileal ASBT function and protection against proteases.

Authors:  Saminathan Muthusamy; Pooja Malhotra; Mobashir Hosameddin; Amish K Dudeja; Sujata Borthakur; Seema Saksena; Ravinder K Gill; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-08       Impact factor: 4.249

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  A novel bioluminescence-based method to investigate uptake of bile acids in living cells.

Authors:  Alexander L Ticho; Hyunjin Lee; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena; Daesung Lee; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

6.  S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells.

Authors:  Alexander L Ticho; Pooja Malhotra; Christopher R Manzella; Pradeep K Dudeja; Seema Saksena; Ravinder K Gill; Waddah A Alrefai
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

Review 7.  Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection.

Authors:  Jeticia R Sistrunk; Kourtney P Nickerson; Rachael B Chanin; David A Rasko; Christina S Faherty
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 8.  Post-translational modifications of transporters.

Authors:  Lindsay C Czuba; Kathleen M Hillgren; Peter W Swaan
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

9.  Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4.

Authors:  Carolien Out; Jay V Patankar; Marcela Doktorova; Marije Boesjes; Trijnie Bos; Sanna de Boer; Rick Havinga; Henk Wolters; Renze Boverhof; Theo H van Dijk; Anna Smoczek; André Bleich; Vinay Sachdev; Dagmar Kratky; Folkert Kuipers; Henkjan J Verkade; Albert K Groen
Journal:  J Hepatol       Date:  2015-05-27       Impact factor: 25.083

10.  Functional transformations of bile acid transporters induced by high-affinity macromolecules.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Farzana Alam; Jooho Park; Kyung Eun Lee; Hyesung Jeon; Kwangmeyung Kim; Ick Chan Kwon; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Sci Rep       Date:  2014-02-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.